ATE426808T1 - Proteininteraktionsdifferenzabbildung - Google Patents

Proteininteraktionsdifferenzabbildung

Info

Publication number
ATE426808T1
ATE426808T1 AT03766029T AT03766029T ATE426808T1 AT E426808 T1 ATE426808 T1 AT E426808T1 AT 03766029 T AT03766029 T AT 03766029T AT 03766029 T AT03766029 T AT 03766029T AT E426808 T1 ATE426808 T1 AT E426808T1
Authority
AT
Austria
Prior art keywords
protein interaction
multicomponent
complex
interaction difference
elution
Prior art date
Application number
AT03766029T
Other languages
English (en)
Inventor
William Rich
Egisto Boschetti
Lee Lomas
Tai-Tung Yip
Original Assignee
Bio Rad Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories filed Critical Bio Rad Laboratories
Application granted granted Critical
Publication of ATE426808T1 publication Critical patent/ATE426808T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03766029T 2002-07-24 2003-07-23 Proteininteraktionsdifferenzabbildung ATE426808T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39864102P 2002-07-24 2002-07-24
US44553603P 2003-02-06 2003-02-06

Publications (1)

Publication Number Publication Date
ATE426808T1 true ATE426808T1 (de) 2009-04-15

Family

ID=30773100

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03766029T ATE426808T1 (de) 2002-07-24 2003-07-23 Proteininteraktionsdifferenzabbildung

Country Status (7)

Country Link
US (1) US7348184B2 (de)
EP (1) EP1552302B1 (de)
JP (1) JP4587954B2 (de)
AT (1) ATE426808T1 (de)
AU (1) AU2003256806A1 (de)
DE (1) DE60326864D1 (de)
WO (1) WO2004009798A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229294A1 (en) 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
EP1681983A4 (de) 2003-10-14 2008-12-10 Monogram Biosciences Inc Rezeptor-tyrosin-kinase-signalpfad-analyse für diagnose und therapie
US7707134B2 (en) * 2005-01-14 2010-04-27 Siemens Medical Solutions Usa, Inc. System and method for molecular diagnosis of depression based on boosting classification
US7672916B2 (en) * 2005-08-16 2010-03-02 The Trustees Of Columbia University In The City Of New York Methods, systems, and media for music classification
US20080023630A1 (en) * 2005-11-22 2008-01-31 Ciphergen Biosystems Inc. Polymer probe doped with conductive material for mass spectrometry
CA2630823C (en) 2005-12-13 2015-02-10 Exthera Ab Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
US8217338B2 (en) * 2008-10-10 2012-07-10 Excellims Corporation Method and apparatus for chemical and biological sample separation
US20090215085A1 (en) * 2006-01-27 2009-08-27 Eastern Virginia Medical School Proteomic Fingerprinting of Human IVF-Derived Embryos: Identification of Biomarkers of Developmental Potential
KR101716241B1 (ko) 2009-12-01 2017-03-14 엑스테라 메디컬 코퍼레이션 표면 고정화된 다당류를 이용하여 혈액으로부터 사이토카인을 제거하는 방법
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US9746458B2 (en) * 2011-04-27 2017-08-29 Loma Linda University Medical Center Dynactin subunit p62 biomarker for neurological conditions
SG11201407505XA (en) * 2012-06-07 2014-12-30 Somalogic Inc Aptamer-based multiplexed assays
EP2861273B1 (de) 2012-06-13 2017-08-23 ExThera Medical Corporation Verwendung von heparin und kohlenhydraten zur behandlung von krebs
BR112015009138A2 (pt) 2012-10-23 2020-10-20 Caris Life Sciences Switzerland Holdings, S.A.R.L. métodos para caracterizar um câncer
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
WO2014100434A1 (en) 2012-12-19 2014-06-26 Caris Science, Inc. Compositions and methods for aptamer screening
WO2014209782A1 (en) 2013-06-24 2014-12-31 Exthera Medical Corporation Blood filtration system containing mannose coated substrate
CN105705177B (zh) 2013-11-08 2019-10-22 艾克塞拉医疗公司 使用吸附介质诊断感染性疾病的方法
WO2015164198A1 (en) 2014-04-24 2015-10-29 Exthera Medical Corporation Method for removing bacteria from blood using high flow rate
CA2959975A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
US10386365B2 (en) 2015-12-07 2019-08-20 Nanohmics, Inc. Methods for detecting and quantifying analytes using ionic species diffusion
US11988662B2 (en) 2015-12-07 2024-05-21 Nanohmics, Inc. Methods for detecting and quantifying gas species analytes using differential gas species diffusion
US10386351B2 (en) 2015-12-07 2019-08-20 Nanohmics, Inc. Methods for detecting and quantifying analytes using gas species diffusion
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
EP3422943A4 (de) 2016-03-02 2019-10-16 ExThera Medical Corporation Verfahren zur behandlung von arzneimittelintoxikation
ITUA20163876A1 (it) * 2016-05-27 2017-11-27 Univ Del Salento Biorecettore per ioni metallici.
US20210072255A1 (en) 2016-12-16 2021-03-11 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
WO2020096631A2 (en) 2018-11-07 2020-05-14 Seer, Inc. Compositions, methods and systems for protein corona analysis and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234811A (en) * 1991-09-27 1993-08-10 The Scripps Research Institute Assay for a new gaucher disease mutation
US5571729A (en) * 1992-06-17 1996-11-05 Wako Pure Chemical Industries, Ltd. Process for separating complex
ES2201077T3 (es) * 1993-05-28 2004-03-16 Baylor College Of Medicine Metodo y espectrometro de masas para la desorcion e ionizacion de analitos.
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
EP1021558A1 (de) * 1997-10-10 2000-07-26 President And Fellows Of Harvard College Oberflächengebundene, doppelsträngige dna-protein-arrays
US6265715B1 (en) 1998-02-02 2001-07-24 Helene Perreault Non-porous membrane for MALDI-TOFMS
AU4338300A (en) * 1999-04-09 2000-11-14 Geron Corporation A second mammalian tankyrase
CA2408375A1 (en) * 2000-05-12 2001-11-22 Charles Pidgeon High throughput chromatographic systems
US20030091976A1 (en) * 2001-11-14 2003-05-15 Ciphergen Biosystems, Inc. Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry

Also Published As

Publication number Publication date
WO2004009798A3 (en) 2004-10-07
AU2003256806A8 (en) 2004-02-09
AU2003256806A1 (en) 2004-02-09
EP1552302B1 (de) 2009-03-25
EP1552302A2 (de) 2005-07-13
JP2005534043A (ja) 2005-11-10
WO2004009798A2 (en) 2004-01-29
DE60326864D1 (de) 2009-05-07
JP4587954B2 (ja) 2010-11-24
US20040146937A1 (en) 2004-07-29
EP1552302A4 (de) 2006-09-13
US7348184B2 (en) 2008-03-25

Similar Documents

Publication Publication Date Title
ATE426808T1 (de) Proteininteraktionsdifferenzabbildung
WO2003072803A3 (en) Nanostructures containing antibody assembly units
NO996243L (no) Retentatkromatografi og proteinchipsrekker med anvendelse innen biologi og medisin
FR14C0066I2 (fr) 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
WO2006084130A3 (en) Ultra-sensitive detection systems using multidimension signals
ATE327511T1 (de) Proteom-analyseverfahren
AU2003224674A8 (en) Compounds and methods for analyzing the proteome
WO2005118857A3 (en) Methods and agents for screening for compounds capable of modulating vegf expression
DK0600866T3 (da) Præparater og fremgangsmåder til identifikation af biologisk aktive molekyler
NO974666D0 (no) Sammenföyningsanordning for plateformete konstruksjonsdeler, samt möbelkonstruksjon
DE59603145D1 (de) Vorrichtung zur Zugabe von Reinigungsmitteln, insbesondere für Geschirrspülmaschinen
ATE437185T1 (de) Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon
ATE366419T1 (de) Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
TR199800679T2 (xx) Kiral metil fenil oksazolidinon.
DK0946873T3 (da) Fremgangsmåde til diagnose af allergisk bronkopulmonal aspergillose
DE69839000D1 (de) Analysegerät, Flüssigkeitschromatographieanalysator und Verfahren dafür
WO2002014351A3 (en) α7 NICOTINIC RECEPTOR PEPTIDES AS LIGANDS FOR β AMYLOID P EPTIDES
NO20021787D0 (no) Fremgangsmåte for bestemmelse av stoffer ved hjelp av evaneschensfeltfremgangsmåten
NO20062309L (no) Metode for prosessering av seismiske data tilegnet ved hjelp av multikomponent sensorer
WO2003072595A3 (en) Methods and products based on oligomerization of stress proteins
NL194335B (nl) Werkwijze voor het bepalen van de concentratie van een anti-microbiÙle verbinding in een monster.
ATA13642000A (de) Vorrichtung zum lageverändern und feststellen von teilen, z.b. lordosenstützen, von möbeln zum sitzen und/oder liegen
DE59709109D1 (de) Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease
NO20013761D0 (no) Fremgangsmåte til bestemmelse av den varige utmattingsstyrken for korrosjonsutsatte forbindelser
DE69005088D1 (de) Vibrierende seismische Quelle, insbesondere anwendbar in Bohrlöchern.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties